Predicting the effectiveness of omalizumab in patients with refractory chronic rhinosinusitis with nasal polyps comorbid with asthma based on inflammatory biomarkers

Update your browser to view ScienceDirect correctly.

Your technical details and browser version:

Request ID: 8f1c624e9fb4aab5-LAX IP: 116.62.10.13 UTC time: 2024-12-14T07:12:10+00:00 Browser: Mozilla/5.0 (X11; U; Linux x86_64; en-US; rv:1.9.1.4) Gecko/20091030 Gentoo Firefox/3.5.4